Pyridine → HCID 86721740, compound
Reaction equation
Cl.[C@@H:2]12[CH:7]([CH2:8][NH:9][C:10]3[C:15]([C:16]4[CH:21]=[CH:20][C:19]([O:22][C:23]5[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=5)=[CH:18][CH:17]=4)=[C:14]([NH2:29])[N:13]=[CH:12][N:11]=3)[C@@H:6]1[CH2:5][NH:4][CH2:3]2.N1C=CC=CC=1.[C:36](Cl)(=[O:39])[CH:37]=[CH2:38].C(Cl)Cl>>[NH2:29][C:14]1[N:13]=[CH:12][N:11]=[C:10]([NH:9][CH2:8][CH:7]2[C@@H:6]3[C@H:2]2[CH2:3][N:4]([C:36](=[O:39])[CH:37]=[CH2:38])[CH2:5]3)[C:15]=1[C:16]1[CH:17]=[CH:18][C:19]([O:22][C:23]2[CH:24]=[CH:25][CH:26]=[CH:27][CH:28]=2)=[CH:20][CH:21]=1Participants
Procedure
To a round bottom flask containing N-[(1S,5R)-1-(3-Aza-bicyclo[3.1.0]hex-6-yl)methyl]-5-(4-phenoxy-phenyl)-pyrimidine-4,6-diamine hydrochloride (259.68 mg; 0.63 mmol; 1.00 eq.) in pyridine (1.00 ml; 12.36 mmol; 19.52 eq.) was added acryloyl chloride (0.05 ml; 0.63 mmol; 1.00 eq.) in DCM (3.00 ml; 46.80 mmol; 73.88 eq.) over 1 h at 0° C. The reaction mixture was allowed to warm to room temperature and stirred overnight. It was concentrated and the crude product was subjected to preparative HPLC. Fractions containing the desired product were combined and lyophilized overnight to afford 1-((1R,5S)-6-(((6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl)amino)methyl)-3-azabicyclo[3.1.0]hexan-3-yl)prop-2-en-1-one as a white solid (2.1 mg, 0.6%). HPLC purity: 99%. MS: m/z=428[M+H]+. 1H NMR (CD3OD) δ 8.24 (s, 1H), 7.21-7.46 (m, 9H), 6.53 (m, 1H), 6.22 (m, 1H), 5.74 (m, 1H), 3.77 (m, 2H), 3.69 (m, 1H), 3.41 (m, 2H), 1.70 (m, 2H), 0.93 (m, 2H).
Workup
- concentrationIt was concentrated
- additionFractions containing the desired product
- waitlyophilized overnight
Sources & evidence
- ORD record
- ord-1212a6acf9ac4481805afb2202e02022
- Source dataset
- uspto-grants-2015_07
- Patent number
- US09073947B2
Reaction notes
Loading…